Effects of quality indicator monitoring for glucocorticoid-induced osteoporosis and trends of drug treatment in a Japanese hospital-Reference-Cited by-同舟云学术

Effects of quality indicator monitoring for glucocorticoid-induced osteoporosis and trends of drug treatment in a Japanese hospital

Published:2018-05 Issue:5 Volume:21 Page:975-981
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Suda Masei¹^ORCID,Suyama Yasuhiro¹,Ohde Sachiko²,Tsuda Tokutaro¹,Sawada Haruki¹,Kishimoto Mitsumasa¹,Okada Masato¹

Affiliation:

1. Immuno-Rheumatology Center; St. Luke's International Hospital; St. Luke's International University; Tokyo Japan

2. Graduate School of Public Health; St. Luke's International University; OMURA Susumu & Mieko Memorial St. Luke's Center for Clinical Academia; Tokyo Japan

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1756-185X.13310/fullpdf

Reference28 articles.

1. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation;Ray;J Bone Miner Res,1997

2. Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment;King;Osteoporos Int,2005

3. Use of oral corticosteroids and risk of fractures;Staa;J Bone Miner Res,2005

4. Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008);Majumdar;J Clin Endocrinol Metab,2012

5. Management and treatment of osteoporosis in patients receiving long-term glucocorticoid treatment: current status of adherence to clinical guidelines and related factors;Kirigaya;Intern Med,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Steroid-Induced Osteoporosis Prevention Using Tracing Reports in Collaboration between Hospitals and Community Pharmacists;Pharmacy;2024-05-15

2. Bad to the bones: prescribing of drugs for the prevention and treatment of osteoporosis in patients on chronic glucocorticoids;Archives of Osteoporosis;2023-03-01

3. A bibliometric and visualization analysis of glucocorticoid-induced osteoporosis research from 2012 to 2021;Frontiers in Endocrinology;2022-08-05

4. Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club;Frontiers in Endocrinology;2022-06-09

5. Focus and features of prescribing indications spanning multiple chronic conditions in older adults: A narrative review;Journal of Multimorbidity and Comorbidity;2021-01-01